THE IMPORTANCE OF PHARMACEUTICAL CARE IN HYPERTENSIVE PATIENTS: AN INTEGRATIVE LITERATURE REVIEW
Abstract
Systemic arterial hypertension is a chronic condition with a high global prevalence, associated with significant cardiovascular outcomes and the need for continuous care strategies focused on clinical control and therapeutic adherence. In this context, the present study aimed to analyze the importance of pharmaceutical care in the follow-up of hypertensive patients, through an integrative literature review. The methodology adopted followed the steps proposed for integrative reviews, including defining the guiding question, establishing inclusion and exclusion criteria, searching databases such as MEDLINE, LILACS, and SciELO, selecting studies, extracting data, and performing content analysis. Studies published between 2021 and 2026, available in full text, in Portuguese, English, and Spanish, were included, totaling 15 studies in the final sample of the review. As a result, it was observed that structured pharmaceutical interventions, such as pharmacotherapeutic follow-up, health education, and the use of digital technologies, were associated with improved treatment adherence, blood pressure control, and prevention of complications, although the findings should be interpreted considering the methodological heterogeneity of the included studies. Furthermore, it was found that the pharmacist's role promotes the rational use of medications, the identification of pharmacotherapy-related problems, and the improvement of healthcare services. It is concluded that pharmaceutical care represents a relevant strategy in the management of hypertension, with the potential to contribute to better clinical outcomes and the strengthening of the organization of health services.
References
ALBABTAIN, M. A. et al. Impact of a community pharmacy-based medication therapy management program on clinical and humanistic outcomes in patients with hypertension. Journal of Clinical Pharmacy and Therapeutics, 2024. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/39090152/ Acesso em abr. 2026.
AL-BABTAIN, M. A. et al. Impact of community-pharmacist-led medication review on outcomes in patients with long-term conditions. Research in Social and Administrative Pharmacy, 2022. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/33965357/ Acesso em abr. 2026.
CANGUÇU, E. et al. Use of text messages to promote medication adherence and reduce blood pressure in patients with hypertension: the ESSENCE study. Cadernos de Saúde Pública, 2024. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/39775770/ Acesso em mai. 2026.
DOHRN, E. et al. Evaluation of a telehealth-based pharmacist-led chronic care program on blood pressure control. Journal of the American Pharmacists Association, 2024. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/37595956/ Acesso em mai. 2026.
GUTIERREZ, M. M.; SAKULBUMRUNGSIL, R. Effectiveness of a pharmacist-led expert system intervention for medication adherence and blood pressure control of adults with hypertension: a randomized controlled trial. Research in Social and Administrative Pharmacy, v. 19, n. 6, p. 931-943, 2023. DisponÃvel em: https://www.researchgate.net/publication/369134483 Acesso em abr. 2026.
IBRAHIM, O. M et al. The impact of telepharmacy on hypertension management in the United Arab Emirates. Pharmacy Practice, v. 20, n. 4, p. 2734, 2022. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/36793920/ Acesso em abr. 2026.
LI, X. et al. Effectiveness of pharmaceutical care for patients with hypertension in a community setting: a randomized controlled trial. International Journal of Clinical Pharmacy, 2021. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/34933984/ Acesso em abr. 2026.
MARGOLIS, K. L. et al. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the Hyperlink 3 trial. JAMA Network Open, 2022. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/36281763/ Acesso em mai. 2026.
PRICE, M. J. et al. A systematic review of economic evaluations of pharmacist services. International Journal of Pharmacy Practice, 2023. DisponÃvel em: https://academic.oup.com/ijpp/article/31/5/459/7237933 Acesso em mai. 2026.
RAMPAMBA, E. M. et al. Development of quality indicators for hypertension management at primary health care level. BMC Health Services Research, 2025. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/39402282/ Acesso em abr. 2026.
SANTSCHI, V. et al. Team-based care for improving hypertension management: a pragmatic randomized controlled trial. Frontiers in Cardiovascular Medicine, 2021. DisponÃvel em: https://www.frontiersin.org/articles/10.3389/fcvm.2021.760662 Acesso em abr. 2026.
TORRES-ROBLES, A. et al. Effectiveness of a medication adherence management intervention by community pharmacists in hypertension. Research in Social and Administrative Pharmacy, 2022. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/33782092/ Acesso em abr. 2026.
TRECIKIENE, I. et al. Hypertension management and drug-related problems: a narrative review. Journal of Clinical Medicine, 2023. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/37601158/ Acesso em mai. 2026.
WANG, Y. et al. Efficacy of pharmaceutical care in patients with type 2 diabetes mellitus and hypertension after hospital discharge. BMC Health Services Research, 2022. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/35685555/ Acesso em abr. 2026.
WASZYK-NOWACZYK, M. et al. The critical role of community pharmacists in blood pressure screening. International Journal of Environmental Research and Public Health, 2024. DisponÃvel em: https://pubmed.ncbi.nlm.nih.gov/39143725/ Acesso em abr. 2026.
License
Copyright (c) 2026 RECIMA21 - Revista CientÃfica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veÃculo de divulgação, seguindo os padrões nacionais e internacionais de publicação.Â